Kairos Pharma Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Kairos Pharma Ltd
Access all reports
Kairos Pharma Ltd is a biopharmaceutical company focused on the development of cancer therapies. The company is engaged in researching and advancing novel treatments targeting various types of cancer through immunotherapy, targeted therapy, and combination approaches. The company is headquartered in Los Angeles, California, and its shares are listed on the OTC markets.
Latest articles
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
Ticker symbol
KAPA
Country
🇺🇸 United States